Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

INTERFERON BETA-1A for Clinically isolated syndrome: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 14 adverse event reports in the FDA FAERS database where INTERFERON BETA-1A was used for Clinically isolated syndrome.

Most Reported Side Effects for INTERFERON BETA-1A

Side Effect Reports % Deaths Hosp.
Multiple sclerosis relapse 5,931 8.8% 45 3,123
Influenza like illness 4,475 6.6% 12 861
Memory impairment 3,468 5.1% 3 547
Multiple sclerosis 3,412 5.1% 185 960
Fatigue 3,164 4.7% 11 736
Fall 3,128 4.6% 48 1,571
Gait disturbance 3,031 4.5% 18 892
Death 2,766 4.1% 2,765 127
Pain 2,692 4.0% 19 677
Headache 2,533 3.8% 8 667
Drug ineffective 2,238 3.3% 19 449
Injection site pain 2,132 3.2% 2 356
Malaise 2,000 3.0% 24 510
Pyrexia 1,688 2.5% 21 574
Hypoaesthesia 1,685 2.5% 5 490

Other Indications for INTERFERON BETA-1A

Multiple sclerosis (56,475) Product used for unknown indication (7,473) Relapsing-remitting multiple sclerosis (2,058) Maternal exposure timing unspecified (245) Relapsing multiple sclerosis (192) Secondary progressive multiple sclerosis (89) Covid-19 (31) Primary progressive multiple sclerosis (27) Exposure via father (20) Progressive multiple sclerosis (19)

Other Drugs Used for Clinically isolated syndrome

OFATUMUMAB (1,075) SIPONIMOD (147) GLATIRAMER (59) FINGOLIMOD (18) INTERFERON BETA-1B (18) OZANIMOD (18) DIMETHYL (7)

Related Pages

INTERFERON BETA-1A Full Profile All Clinically isolated syndrome Drugs INTERFERON BETA-1A Demographics INTERFERON BETA-1A Timeline